Does RITUXIMAB Cause Interstitial lung disease? 2,458 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,458 reports of Interstitial lung disease have been filed in association with RITUXIMAB (Rituxan). This represents 1.4% of all adverse event reports for RITUXIMAB.
2,458
Reports of Interstitial lung disease with RITUXIMAB
1.4%
of all RITUXIMAB reports
364
Deaths
725
Hospitalizations
How Dangerous Is Interstitial lung disease From RITUXIMAB?
Of the 2,458 reports, 364 (14.8%) resulted in death, 725 (29.5%) required hospitalization, and 241 (9.8%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for RITUXIMAB.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
TOCILIZUMAB (1,229)
Which RITUXIMAB Alternatives Have Lower Interstitial lung disease Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE